SCHEMBL5907265

SCHEMBL5907265

N#Cc1ccccc1-c1ccc(-n2ncc(CN3CCOCC3)c2-c2ccccc2F)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.44
CYP2A13 Q16696 1/20 0.43
SLC2A2 P11168 1/20 0.41
PDE10A Q9Y233 1/20 0.41
ALDH1A1 P00352 2/20 0.40
HSD17B10 Q99714 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2D6 P10635 2/20 0.40
CLK4 Q9HAZ1 2/20 0.40
ACHE P22303 1/20 0.40
CNR2 P34972 1/20 0.40
TBK1 Q9UHD2 2/20 0.40
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
POLB P06746 1/20 0.39
TSHR P16473 1/20 0.39
KMT2A Q03164 1/20 0.39
KDM4E B2RXH2 2/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5907238 0.90 CYP2A13 (0.50) CYP2A13ALDH1A1CYP3A4CYP2D6SSTR5
SCHEMBL27653906 0.90 CYP2A13 (0.41) NR3C1CYP2A13PDE10AALDH1A1HSD17B10
SCHEMBL5731736 0.90 CYP2A13 (0.44) CYP2A13PDE10AALDH1A1HSD17B10CYP3A4
SCHEMBL5732227 0.85 ADORA2A (0.48) CYP2A13ALDH1A1HSD17B10CYP1A2CYP3A4
SCHEMBL5907262 0.85 CYP2A13 (0.45) CYP2A13PDE10AALDH1A1CYP1A2CYP3A4
SCHEMBL5907335 0.85 CYP2A13 (0.47) CYP2A13ALDH1A1CNR2POLBKMT2A
SCHEMBL5907245 0.85 CYP2A13 (0.44) CYP2A13ALDH1A1MEN1KMT2ASSTR5
SCHEMBL5731706 0.84 CYP2A13 (0.46) CYP2A13ALDH1A1MEN1KMT2ASSTR5
SCHEMBL5730763 0.84 KMT2A (0.46) CYP2A13ALDH1A1CYP1A2KMT2AKDM4E
SCHEMBL5907384 0.84 SLC2A1 (0.44) NR3C1CYP2A13ALDH1A1HSD17B10CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060264419-A1 Substituted pyrazoles MERCK PATENT GMBH (DE) 2006-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264419-A1 Substituted pyrazoles HTR3A, HTR1A, HTR1D NR3C1 192/4885CYP2A13 659/4885SLC2A2 2979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.